CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for WorldHeart Corporation (USA) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

WorldHeart Corporation (USA)
4750 Wiley Post Way, Suite 120
Phone: (801) 355-6255p:801 355-6255 SALT LAKE CITY, UT  84116  United States Fax: (302) 636-5454f:302 636-5454

This company ceased filing statements with the SEC on 8/13/2012.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
World Heart Corporation is a United States-based company. The Company's business is focused on the development and commercialization of ventricular assist devices (VADs) for adults, children and infants suffering from heart failure. The Company's devises, including ventricular assist devices, which are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation; bridge-to-transplant (BTT) therapy, which involves implanting a ventricular assist device in a transplant-eligible patient to maintain or improve the patient's health until a donor heart becomes available; destination therapy (DT), which implanting of a ventricular assist device to provide long-term support for a patient not for the moment eligible for a natural heart transplant; and bridge-to-recovery (BTR), which involves the use of ventricular assist devices to restore a patient's cardiac function.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201212/31/2011YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Michael S.Estes 74 6/28/2007 4/9/2007
Interim Principal Executive Officer, Chief Financial Officer, Executive Vice President, Secretary Morgan R.Brown 4/21/2012 8/10/2009
Senior Vice President - Scientific Affairs John C.Woodard 56 1/1/2013 6/17/2010
4 additional Officers and Directors records available in full report.

Business Names
Business Name
WHRT
World Heart B.V.
World Heart Inc.

General Information
Number of Employees: 26 (As of 12/31/2011)
Outstanding Shares: 27,517,749 (As of 3/31/2012)
Shareholders: 76
Stock Exchange: NASD
Federal Tax Id: 522247240
Fax Number: (302) 636-5454


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023